On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...
Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback